Silver Book Fact

A new study reports that using optogenetics, stimulating specific brain cells using light, may provide better results for Parkinson’s patients than traditional deep brain stimulation because of the ability to control different cells at specific times.

Gradinaru V, Mogri M, Thompson K, Henderson J, et al. Optical Deconstruction of Parkinsonian Neural Circuitry. Science. 2009; 324(5925): 354-9. http://www.ncbi.nlm.nih.gov/pubmed/19299587

Reference

Title
Optical Deconstruction of Parkinsonian Neural Circuitry
Publication
Science
Publication Date
2009
Authors
Gradinaru V, Mogri M, Thompson K, Henderson J, et al.
Volume & Issue
Volume 324, Issue 5925
Pages
354-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Medicines Allow Patients to Remain Independent Longer: New Alzheimer’s medicine delays need for costly home care  
  • Slowing the progression of Parkinson’s disease by just 10% would save $327 million (in direct and indirect costs) to the U.S. annually.  
  • The U.S. Food and Drug Administration has approved five drugs that temporarily improve Alzheimer’s disease symptoms.  
  • A current drug in development addresses the underlying cause of type 2 diabetes by modulating genes responsible for insulin sensitization.  
  • Impact of Slowed Progression on Severe Stage, Americans Age 65 and Older with Alzheimer’s, 2010-2050